At the Department of Laboratory Medicine (KILM) basic and applied research are combined to characterize the pathomechanisms of non-communicable diseases.
Our mission is to translate our experimental research results to human medicine, including the identification and development of novel biomarkers and innovative therapeutics. To this end, training of graduate students as well as the mentoring of MDs, MD/PhDs and PhDs is a core part of our mission.
Areas of research include cardiovascular diseases, including atherosclerosis, aneurysms, and myocardial infarction, the associated metabolic diseases, such as fatty liver disease and obesity, and hematological malignancies and autoimmune diseases. A major theme of our research focuses on elucidating the role of inflammation and other various aspects of immunity in modulating these pathologies and how this knowledge can be exploited for the development of better treatment strategies.